John Jeter, MD, has announced plans to retire from his role as President and CEO of HaysMed, part of The University of Kansas Health System, effective Jan. 1, 2018. Jeter joined HaysMed in 1996.
Category: University of Kansas
Boy could be asked to leave US before cancer treatment is complete
A 9-year-old boy who is in United States for special cancer treatment, could be asked to leave before his procedures are complete. A statement made on the family’s Twitter account reads: “Devastating news today that our immigration status only allows Alex to stay until April.
New drug offers hope for patients with bladder cancer
A bladder cancer drug discovered and developed at The University of Kansas Cancer Center is set to become its first cancer drug to go from bench to bedside. KU Cancer Center’s nationally recognized proof-of-concept center and product development arm, the Institute for Advancing Medical Innovation , translates laboratory and bedside discoveries into new drugs, diagnostic tests and medical devices with the goal of advancing promising medical innovations to patients.
New NMRMC dermatology clinic opens
Dermatologist P. Christy Parham-Vetter, MD, said the day started a little slowly, but she has a great staff and patients were understanding. Vetter said there are not enough dermatologists to go around anywhere, particularly in rural areas.
Retiring KU professor invented widely used drugs for HIV
In this Wednesday, Dec. 14, 2016 photo, University of Kansas distinguished professor of pharmaceutical chemistry Valentino Stella poses at Simons Laboratories on West Campus of the University of Kansas in Lawrence, Kan.